JP4606604B2 - Isomultiphlorenol synthase and the enzyme gene - Google Patents
Isomultiphlorenol synthase and the enzyme gene Download PDFInfo
- Publication number
- JP4606604B2 JP4606604B2 JP2001011612A JP2001011612A JP4606604B2 JP 4606604 B2 JP4606604 B2 JP 4606604B2 JP 2001011612 A JP2001011612 A JP 2001011612A JP 2001011612 A JP2001011612 A JP 2001011612A JP 4606604 B2 JP4606604 B2 JP 4606604B2
- Authority
- JP
- Japan
- Prior art keywords
- synthase
- isomultiphlorenol
- isomultiflorenol
- polypeptide
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000790 Enzymes Proteins 0.000 title claims description 9
- NSSALFVIQPAIQK-FPLPWBNLSA-N (Z)-2-Nonen-1-ol Chemical compound CCCCCC\C=C/CO NSSALFVIQPAIQK-FPLPWBNLSA-N 0.000 claims description 17
- BHVJSLPLFOAMEV-UHIFYLTQSA-M 20-Epibryonolic acid Natural products C([C@H]1[C@]2(C)CC3)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@]2(C)C1=C3[C@@]2(C)CC[C@H](O)C(C)(C)[C@@H]2CC1 BHVJSLPLFOAMEV-UHIFYLTQSA-M 0.000 claims description 17
- BHVJSLPLFOAMEV-UHFFFAOYSA-N Bryonolic acid Natural products C1CC2(C)C3CC(C)(C(O)=O)CCC3(C)CCC2(C)C2=C1C1(C)CCC(O)C(C)(C)C1CC2 BHVJSLPLFOAMEV-UHFFFAOYSA-N 0.000 claims description 17
- MCSMMGJCXCBSKD-UHFFFAOYSA-N Isomultifluorenol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C1(C)CCC1(C)CCC(C)(C)CC12 MCSMMGJCXCBSKD-UHFFFAOYSA-N 0.000 claims description 17
- MCSMMGJCXCBSKD-XCHVDQMNSA-N isomultiflorenol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@]1(C)CC[C@@]1(C)CCC(C)(C)C[C@H]12 MCSMMGJCXCBSKD-XCHVDQMNSA-N 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 12
- 229920001184 polypeptide Polymers 0.000 claims description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 150000003505 terpenes Chemical class 0.000 claims description 5
- 239000013598 vector Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 2
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 description 20
- 210000004027 cell Anatomy 0.000 description 14
- 108020004999 messenger RNA Proteins 0.000 description 13
- 244000302544 Luffa aegyptiaca Species 0.000 description 12
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 12
- 108010076161 Cycloartenol synthase Proteins 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 9
- 108010059597 Lanosterol synthase Proteins 0.000 description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 150000003648 triterpenes Chemical class 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 108700026244 Open Reading Frames Proteins 0.000 description 5
- 102000030633 squalene cyclase Human genes 0.000 description 5
- 108010088324 squalene cyclase Proteins 0.000 description 5
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 description 4
- 108010072389 Isomultiflorenol synthase Proteins 0.000 description 4
- 108010067839 Lupeol synthase Proteins 0.000 description 4
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 4
- 229940031439 squalene Drugs 0.000 description 4
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 4
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- 108020004518 RNA Probes Proteins 0.000 description 3
- 239000003391 RNA probe Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229930000223 plant secondary metabolite Natural products 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 241000219108 Bryonia dioica Species 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 2
- 241000219104 Cucurbitaceae Species 0.000 description 2
- 108030005251 Cucurbitadienol synthases Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 101100381454 Glycyrrhiza glabra GgbAS1 gene Proteins 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 102100032011 Lanosterol synthase Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000010230 functional analysis Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000009831 Citrullus lanatus Nutrition 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 101150094690 GAL1 gene Proteins 0.000 description 1
- 102100028501 Galanin peptides Human genes 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 101100121078 Homo sapiens GAL gene Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000036978 cell physiology Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- LULXBAGMGMJJRW-UHFFFAOYSA-N n,2-bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)CC(=O)N[Si](C)(C)C LULXBAGMGMJJRW-UHFFFAOYSA-N 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
【0001】
【発明の属する技術分野】
本発明はイソマルチフロレノールの生合成酵素であるイソマルチフロレノールシンターゼ、該酵素をコードするDNAおよびイソマルチフロレノールおよび/またはこのイソマルチフロレノールから生合成される各種テルペノイドを製造する方法に関する。
【0002】
【従来の技術】
ブリオノール酸は、トリテルペノイドに分類される植物二次代謝産物の一種で、ウリ科ヘチマ属植物のヘチマ(Luffa cylindrica Roem.)、カラスウリ属植物のキカラスウリ(Trichosanthes kirilowii var. japonica)、スイカ属植物のスイカ(Citrullus lanatus)、ブリオニア属植物のブリオニア・ディオイカ(Bryonia dioica)などウリ科植物の根に含有されていることが明らかになっている。ブリオノール酸およびその誘導体は他の植物由来のトリテルペノイドとは異なった構造を有しており、他にはない生理活性を持つことが期待されるとともに、医薬用の原料としても注目されている。
【0003】
しかしながら、ブリオノール酸およびその誘導体を製造する場合、植物体を原料として用いる場合は、栽培に多額のコストがかかるとともに、その生産性は極めて低いものとならざるを得ない。そのため、ヘチマの細胞培養によるトリテルペノイドの生産に関する研究がなされ、ヘチマのカルスがブリオノール酸およびその誘導体を生産することを報告している[Plant and Cell Physiology 25,1571-1574(1984); Organic Magnetic Resonance 22,93-100(1984)]。
また、ブリオノール酸の生合成経路についても幾つか研究がなされており、メバロン酸経路により生成した2,3−オキシドスクワレンが環化することにより生成したイソマルチフロレノールが生合成前駆体と考えられ、生成したイソマルチフロレノールが酸化されることでブリオノール酸が生成するものと考えられる。天然には90以上の異なったタイプのトリテルペン骨格が存在すると言われており、2,3−オキシドスクワレンを環化するβ―アミリンシンターゼ、ルペオールシンターゼなど幾つかのトリテルペン合成酵素が知られている[Eur. J. Biochem. 256 ,238-244 (1998) ; Eur. J. Biochem. 266 ,302-307 (1999)]。しかし、2,3−オキシドスクワレンからブリオノール酸の前駆体であるイソマルチフロレノールの生成を触媒するイソマルチフロレノールシンターゼに関する研究はなされていなかった。
【0004】
【発明が解決しようとする課題】
本発明は、イソマルチフロレノールシンターゼをコードするDNAをクローン化し、その塩基配列を決定し、更にクローン化した組換えDNAを発現させた細胞を用いてイソマルチフロレノールシンターゼ、該酵素をコードするDNAおよびイソマルチフロレノールおよび/またはこのイソマルチフロレノールから生合成される各種テルペノイドを製造することを目的とする。
【0005】
【課題を解決するための手段】
本発明者らは、鋭意研究の結果、カンゾウのβ―アミリンシンターゼcDNAをプローブとしてヘチマ培養細胞のcDNAをスクリーニングし、1種類のオキシドスクワレン環化酵素cDNAをクローニングした。本cDNAの全長のORFを酵母発現ベクターに組込み、ラノステロールシンターゼを欠く酵母に形質転換して機能解析をした結果、該酵母において本来生合成されないイソマルチフロレノールの生産が認められたことから、本cDNAがイソマルチフロレノールシンターゼをコードしていることを確認した。
【0006】
すなわち、本発明の第1の態様は、イソマルチフロレノールシンターゼの酵素活性を有するポリペプチドおよび/または配列番号1に記載のアミノ酸配列を含むポリペプチドである。また、第2の態様は、イソマルチフロレノールシンターゼ酵素活性を有するポリペプチドをコードするヌクレオチド配列を含むDNAおよび/または配列番号1に記載のアミノ酸配列を含むポリペプチドをコードするヌクレオチド配列を含むDNAであり、配列番号2に記載のヌクレオチド配列を含むDNAが挙げられる。本発明の第3の様態は、第1の様態に記載のDNAを含むベクターである。本発明の第4の様態は、上記ベクターで形質転換された細胞である。また、本発明の第5の様態は、上記形質転換細胞を用いて、植物二次代謝産物を製造する方法である。この植物二次代謝産物はイソマルチフロレノールから生合成されるテルペノイドであってもよい。
【0007】
【発明の実施の形態】
以下、本発明を詳細に説明する。
本発明者らは、ブリオノール酸の生産性が高いヘチマ培養細胞よりcDNAライブラリーを作成し、カンゾウのβ―アミリンシンターゼ(GgbAS1) cDNAをプローブとしてスクリーニングを行い、1種類のオキシドスクワレン環化酵素cDNAをクローニングした。得られたcDNAの全長ORFを酵母発現ベクター(pYES2)に組み込み、ラノステロールシンターゼを欠く酵母(GIL77)に形質転換して機能解析をした結果、本cDNAがイソマルチフロレノールシンターゼをコードしていることが確認された。新規に得られたイソマルチフロレノールシンターゼのアミノ酸配列はプローブとして用いたカンゾウのβ―アミリンシンターゼとは67%の相同性があったが、既知のクローンの中にこれ以上高い相同性のものは認められなかった。
【0008】
本発明に係るイソマルチフロレノールシンターゼとは、2,3−オキシドスクワレンからイソマルチフロレノールを生成する反応を触媒する酵素を指しており、その起源は特に限定されないが、好ましくは植物由来であり、そのようなものとしてたとえば以下の実施例に記載のものを挙げることが出来る。
【0009】
【実施例】
以下に実施例を挙げて本発明を更に詳しく説明するが、本発明はこれらの実施例に限定されるものではない。
実施例1 ヘチマ培養細胞株の作成および培養
ヘチマ(Luffa cylindrica)の種子を無菌処理し、無菌発芽させた実生から子葉および茎の切片を切り取り、これを2,4-Dを10-6Mとなるように添加したリンスマイヤー・スクーグ(LS)の寒天培地に移植し、27℃暗所下で培養した。5-7週間後に得られたヘチマのカルスを2,4-Dを10-7Mになるように添加したLSの液体培地に移植し、27℃、暗所にて振盪培養を行い、3年間以上継代培養を行った後、この細胞を2,4-DをNAAに変更したLSの液体培地、27℃、暗所下で継代培養を行った。
【0010】
実施例2 cDNAライブラリーの作成
このようにして得られた培養10日目のヘチマ細胞から、グアニジンチオシアネート/ホットフェノール法により全RNAを抽出し、更にmRNA精製キット(Pharmacia製)を用い、製造者の説明書に従ってPoly(A)+RNAを精製した。精製したPoly(A)+RNAを用い、ZAP-cDNA合成キット(Stratagene製)を用いて製造者の説明書に従ってヘチマcDNAライブラリーを作成した。
【0011】
実施例3 プローブの作成
イソマルチフロレノールシンターゼのクローニングに用いるプローブにはG.glabra由来のGgbAS1β-アミリンシンターゼのアミノ酸残基353-729に相当する1227-bpジオキシゲニン(DIG)ラベルDNAプローブを用いた。本プローブは、GgbAS1をテンプレートとし、配列番号2および配列番号3に示す2種のプライマー、Taq DNAポリメラーゼ、DIG-dNTPミクスチャーを用いて製造者の説明書に従い、PCR法により調製した。
【0012】
実施例4 cDNAライブラリーのスクリーニング
このようにして調製したDIGラベルプローブを用いてヘチマcDNAライブラリーを低ストリンジェンシー条件下でスクリーニングした結果、cDNAライブラリーの200,000プラークから陽性クローンを1種取得し、pBluescript SK(-)ベクターにサブクローニングした。このクローンを両ストランド共にシークエンスした結果、本クローンは2277塩基からなるオープンリーディングフレーム(ORF)を含む2551塩基からなり、分子量87.7kDの759アミノ酸からなる翻訳産物ポリペプチドが想定された。cDNA配列中には、既知のオキシドスクワレン環化酵素配列中に繰り返し認められるQWモチーフ[Trends Biochem. Sci. 19 ,157-158 (1994)]やオキシドスクワレン環化酵素の活性部位であることが指摘されているDCTAEモチーフ[J. Biol. Chem. 269 ,802-804 (1994)]が存在した。
【0013】
実施例5 機能確認
実施例4で得られたcDNAの機能を明らかにするため、得たcDNAのORFをPCRにより増幅し、酵母での発現プラスミドpYES2(Invitrogen社)に組込んだ。PCRは得られたcDNAを鋳型とし、配列番号4と配列番号5で示される塩基配列のプライマーを用い、94℃で40秒間のディネーチャー、50℃で40秒間のアニール、72℃で2分間の伸長反応を1サイクルとし、25サイクル反応させた。得られたPCR産物は制限酵素KpnIとXbaIで処理し、発現プラスミドpYES2のKpnIとXbaIサイトに組込み、これをpYES2-LcOSC3とした。これによりLcOSC3はGAL1プロモーターの下流にセンス方向に導入される。更に得られたpYES2-LcOSC3プラスミドをラノステロール合成酵素欠損株である酵母変異株GIL77に酢酸リチウム法により導入した。培養条件、がラクトースによる発現誘導、トリテルペンモノアルコール画分の調整方法はKushiro,T. et al.文献に記載されている方法と同様に行った[Eur. J. Biochem. 256, 238-244(1998)]。ガラクトースによる発現誘導後、形質転換酵母から生成物を抽出し、TLCにより精製後、トリテルペンモノアルコール画分をLC-MS/MSにより分析した。LC-MS/MSは以下に示すHPLC条件下、LCQ(Thermo Quest)で測定した。
(HPLC条件)
Column: SUPER-ODS(diameter: 4.6mm, length: 200mm; Tosoh製)
Solvent system: 95% CH3CN aq.、Flow rate: 1ml/min、Column temp.: 40℃、Detection: UV205nm、Retention time for isomultiflorenol: 23.9min.
標準品イソマルチフロレノールのMS/MSフラグメントパターンとの比較から、LC-MS/MSにより同定したトリテルペンモノアルコール画分から得られたピークはイソマルチフロレノールであり、本画分から得られた化合物はイソマルチフロレノールのみであった(図1)。尚、イソマルチフロレノールのMSおよびMS/MS分析の結果、MS m/z 409[M+H-H2O]+、MS/MS (precursor ion at m/z 409) 353(10%), 313(22%), 299(57%), 245(65%), 231(91%), 217(100%), 191(71%)の結果を得た。よって本cDNAは、高等植物から得られたオキシドスクワレン環化酵素の1つに位置づけられるイソマルチフロレノールシンターゼ(IMS1)をコードしているものと結論づけた。
【0014】
ヘチマ由来の3種オキシドスクワレン環化酵素、シクロアルテノールシンターゼ(CAS1)[Plant Physiol. 121,1384 (1999)]、機能不明であるオキシドスクワレン環化酵素(OSC2)[Plant Physiol. 122,1457 (2000)]、イソマルチフロレノールシンターゼ(IMS1)のアミノ酸配列を比較した結果、IMS1のアミノ酸配列はCAS1と51%、OSC2と50%の相同性を示した(図2)。更にIMS1のアミノ酸配列と高等植物からクローン化されたオキシドスクワレン環化酵素のアミノ酸配列から系統樹を作成した(図3)。IMS1はβ−アミリンシンターゼと67-66%の相同性、ルペオールシンターゼと61-57%の相同性を示した。IMS1のアミノ酸配列は他のトリテルペンシンターゼと67-57%の低相同性であったことから、イソマルチフロレノールシンターゼはウリ科植物に認められる新しいクラスのトリテルペンシンターゼに分類される。
【0015】
実施例6 ノーザンブロット分析
DIGラベルRNAプローブはBamHI処理CAS1、EcoRI処理OSC2、BamHI処理IMS1からT7RNAポリメラーゼおよびDIG RNA Labeling Mix (Roche Diagnostic製)を用いて製造者の説明書に従って調製した。全RNAはExtract-A-PlantTM RNA Isolation Kit (Clontech製)を用いて抽出した。レーン当たり5μgの全RNAをホルムアルデヒド含有1%アガロースゲルで分離し、正電荷ナイロンメンブラン(Roche Diagnostic製)にブロットした。メンブラン上のRNAを、50mM Na-Pi buffer(pH7.0)、50% ホルムアミド、0.1% N-ラウリルサルコシン、7% SDS、5xSSC、1mg/ml tRNA(yeast)、blocking reagentを含むハイブリダイゼーションバッファー中50℃で、DIGラベルRNAプローブを用いてハイブリダイズし、DIG Nucleic Acid Detection Kit Mix (Roche Diagnostic製)を用いて製造者の説明書に従って検出した(図4)。
【0016】
実施例7 細胞増殖およびブリオノール酸生産のタイムコース
培養開始日後4、8、12、16、20、24日目の細胞増殖およびブリオノール酸の生産の経時変化を示した(図5)。ブリオノール酸の定性分析は以下の方法で行った。培養終了後の細胞を凍結乾燥し、得られた凍結乾燥細胞50mgから酢酸エチル2mlを用いて60℃、1時間の撹拌抽出を2回行った。得られた抽出液に内部標準としてコレステロール1mgを添加し、ロータリーエバポレーターを用いて溶媒を流去した後、乾燥サンプルをピリジン20(l、N,O-ビストリメチルシリルアセトアミド20(lからなる混合溶媒に再溶解し、50℃、1時間インキュベートした。反応後の液1(lを以下に示す条件下、ガスクロマトグラフィーにより分析し、ブリオノール酸の定量を行った。ブリオノール酸の定量は内部標準のTMSi誘導体のピーク面積から算出した。
(ガスクロマトグラフィー分析条件)
Column: Ultra Alloy+-17 capillary column (15m x 0.5mm i.d., film thickness: 1(l, Frontier Lab Ltd.製)、Column temp.: 295℃(isothermal)、 injector and detector temp.: 320℃、Carrier gas: He 3.5ml/min。
ヘチマ培養細胞によるブリオノール酸の生産は対数増殖期の後期から立ち上がる。ブリオノール酸生産のタイムコースとIMS1のmRNAレベル、CAS1のmRNAレベル、OSC2のmRNAレベルを比較した結果、ヘチマ細胞内で3種のオキシドスクワレン環化酵素のmRNAレベルは異なった制御を受けていた(図6)。イソマルチフロレノールシンターゼmRNAレベルは培養16日目、20日目で最も高く、この時点でブリオノール酸合成活性は非常に高い。ところが4、8、24日目ではイソマルチフロレノールシンターゼmRNAレベルは低く、この時点ではブリオノール酸生産はさほど顕著には認められない。一方、シクロアルテノールシンターゼmRNAレベルは4、8日目で高く、この時点では細胞の増殖が顕著に認められる。そして対数増殖期の後期ではmRNAレベルはより低いレベルとなっている。また、オキシドスクワレン環化酵素と推定されるOSC2のmRNAレベルは20、24日目で高く、この時点では細胞は既に安定期に入っている。
【0017】
【発明の効果】
以上記載の如く、イソマルチフロレノールシンターゼをコードするDNAのクローン化に初めて成功し、更にクローン化した組換えDNAを発現させた細胞を用いてイソマルチフロレノールシンターゼ、該酵素をコードするDNAおよびイソマルチフロレノールおよび/またはこのイソマルチフロレノールから生合成される各種テルペノイドを製造することが可能である。
【0018】
【配列表】
【図面の簡単な説明】
【図1】標準品イソマルチフロレノールとpYES2-OSC3形質転換酵母抽出物のHPLCクロマトグラムおよびLC-MS/MSフラグメントを比較した図である。
【図2】CAS1、OSC2、IMS1のアミノ酸配列の比較した図である。相同なアミノ酸を白文字反転で示した。
【図3】高等植物由来オキシドスクワレン環化酵素のアミノ酸配列から作成した系統樹である。方法:UPGMA (Genetyx software)。bAS,β-アミリンシンターゼ;LUS,ルペオールシンターゼ;IMS,イソマルチフロレノールシンターゼ;CAS,シクロアルテノールシンターゼ;CDS,ククルビタジエノールシンターゼ;OSC,オキシドスクワレン環化酵素。
【図4】CAS1,OSC2,IMS1の制限酵素サイトおよびDIGラベルRNAプローブ部位を示す図である。
【図5】細胞増殖およびブリオノール酸生産のタイムコースを示す図である。
【図6】ヘチマ細胞培養時のIMS1 mRNA、CAS1 mRNA、OSC2 mRNA量の変化を示した電気泳動図である。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to isomultiflorenol synthase which is a biosynthetic enzyme of isomultiflorenol, DNA encoding the enzyme, and isomultiflorenol and / or a method for producing various terpenoids biosynthesized from this isomultiflorenol. .
[0002]
[Prior art]
Bryonolic acid is a type of plant secondary metabolite classified as a triterpenoid. It has been found that it is contained in the roots of cucurbitaceae plants such as watermelon (Citrullus lanatus) and Bryonia dioica (Bryonia dioica). Bryonolic acid and its derivatives have a structure different from that of other plant-derived triterpenoids, and are expected to have a physiological activity not found elsewhere, and are also attracting attention as raw materials for pharmaceuticals.
[0003]
However, when producing bryonolic acid and its derivatives, when a plant body is used as a raw material, it costs a great deal of cultivation and its productivity must be extremely low. Therefore, studies have been conducted on the production of triterpenoids by cell culture of loofah, and it has been reported that loofah callus produces bryonolic acid and its derivatives [Plant and Cell Physiology 25,1571-1574 (1984); Organic Magnetic Resonance 22,93-100 (1984)].
Several studies have also been conducted on the biosynthetic pathway of bryonolic acid, and isomultiflorenol produced by cyclization of 2,3-oxide squalene produced by the mevalonic acid pathway is considered to be a biosynthetic precursor. It is considered that bryonolic acid is produced by oxidation of the produced isomultiphlorenol. It is said that more than 90 different types of triterpene skeleton exist in nature, and several triterpene synthases such as β-amylin synthase and lupeol synthase that cyclize 2,3-oxide squalene are known. [Eur. J. Biochem. 256, 238-244 (1998); Eur. J. Biochem. 266, 302-307 (1999)]. However, there has been no research on isomultiphlorenol synthase that catalyzes the production of isomultiphlorenol, which is a precursor of brionolic acid, from 2,3-oxide squalene.
[0004]
[Problems to be solved by the invention]
The present invention clones DNA encoding isomultiphlorenol synthase, determines its nucleotide sequence, and further encodes isomultiphlorenol synthase and the enzyme using a cell expressing the cloned recombinant DNA. The object is to produce DNA and isomultiflorenol and / or various terpenoids biosynthesized from this isomultiflorenol.
[0005]
[Means for Solving the Problems]
As a result of diligent research, the present inventors screened cDNA of loofah cultured cells using licorice β-amylin synthase cDNA as a probe, and cloned one kind of oxidosqualene cyclase cDNA. The full-length ORF of this cDNA was incorporated into a yeast expression vector, transformed into yeast lacking lanosterol synthase, and as a result of functional analysis, production of isomultiflorenol that was not originally biosynthesized in the yeast was observed. It was confirmed that the cDNA encodes isomultiphlorenol synthase.
[0006]
That is, the first aspect of the present invention is a polypeptide having the enzyme activity of isomultiphlorenol synthase and / or a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 1. The second aspect is a DNA comprising a nucleotide sequence encoding a polypeptide having isomultiphlorenol synthase enzyme activity and / or a DNA comprising a nucleotide sequence encoding a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 1. And a DNA comprising the nucleotide sequence set forth in SEQ ID NO: 2. A third aspect of the present invention is a vector containing the DNA described in the first aspect. A fourth aspect of the present invention is a cell transformed with the above vector. Moreover, the 5th aspect of this invention is a method of manufacturing a plant secondary metabolite using the said transformed cell. This plant secondary metabolite may be a terpenoid biosynthesized from isomultiflorenol.
[0007]
DETAILED DESCRIPTION OF THE INVENTION
Hereinafter, the present invention will be described in detail.
The present inventors prepared a cDNA library from cultured hechima cells with high productivity of bryonolic acid, screened using licorice β-amylin synthase (GgbAS1) cDNA as a probe, and one kind of oxidosqualene cyclase cDNA. Was cloned. The full-length ORF of the resulting cDNA was incorporated into a yeast expression vector (pYES2), transformed into yeast lacking lanosterol synthase (GIL77), and functional analysis revealed that this cDNA encodes isomultiflorenol synthase. Was confirmed. The amino acid sequence of the newly obtained isomultiphlorenol synthase was 67% homologous to the licorice β-amylin synthase used as a probe, but some of the known clones have higher homology. I was not able to admit.
[0008]
The isomultiphlorenol synthase according to the present invention refers to an enzyme that catalyzes a reaction for producing isomultiphlorenol from 2,3-oxide squalene, and its origin is not particularly limited, but preferably is derived from a plant. Examples of such a material include those described in the following examples.
[0009]
【Example】
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited to these examples.
Seeds of creation and culture loofah Example 1 loofah cell line (Luffa cylindrica) was sterilized, cut sections of the cotyledons and stems from seedlings germinated under aseptic conditions, which the 2,4-D and 10 -6 M It was transplanted to an agar medium of Rinsmeier Skoog (LS) added as described above and cultured in the dark at 27 ° C. After 5-7 weeks, the callus of loofah obtained was transferred to LS liquid medium supplemented with 2,4-D at 10 -7 M, and cultured at 27 ° C in the dark for 3 years. After subculturing as described above, the cells were subcultured in a liquid medium of LS in which 2,4-D was changed to NAA at 27 ° C. in the dark.
[0010]
Example 2 Preparation of cDNA Library Total RNA was extracted by the guanidine thiocyanate / hot phenol method from the thus obtained 10-day cultured hechima cells, and an mRNA purification kit (Pharmacia) was used. Poly (A) + RNA was purified according to the instructions in A purified poly (A) + RNA was used to prepare a loofah cDNA library using a ZAP-cDNA synthesis kit (Stratagene) according to the manufacturer's instructions.
[0011]
Example 3 Preparation of Probe A 1227-bp dioxygenin (DIG) -labeled DNA probe corresponding to amino acid residues 353-729 of GgbAS1β-amylin synthase derived from G.glabra was used as a probe for cloning of isomultiphlorenol synthase. . This probe was prepared by the PCR method using GgbAS1 as a template and using the two primers shown in SEQ ID NO: 2 and SEQ ID NO: 3, Taq DNA polymerase, and DIG-dNTP mixture according to the manufacturer's instructions.
[0012]
Example 4 Screening of cDNA Library As a result of screening the loofah cDNA library under low stringency conditions using the DIG-labeled probe thus prepared, one positive clone was obtained from 200,000 plaques of the cDNA library, Subcloned into pBluescript SK (-) vector. As a result of sequencing this clone for both strands, this clone was assumed to be a translation product polypeptide consisting of 2551 bases comprising an open reading frame (ORF) consisting of 2277 bases and a molecular weight of 87.7 kD and consisting of 759 amino acids. It is pointed out that the cDNA sequence is the active site of the QW motif [Trends Biochem. Sci. 19, 157-158 (1994)] and oxidosqualene cyclase that are repeatedly observed in known oxidosqualene cyclase sequences. DCTAE motif [J. Biol. Chem. 269, 802-804 (1994)] existed.
[0013]
Example 5 Function Confirmation In order to clarify the function of the cDNA obtained in Example 4, the ORF of the obtained cDNA was amplified by PCR and incorporated into the expression plasmid pYES2 (Invitrogen) in yeast. PCR was performed using the obtained cDNA as a template, using primers of the nucleotide sequences shown in SEQ ID NO: 4 and SEQ ID NO: 5, 94 ° C for 40 seconds, 50 ° C for 40 seconds, and 72 ° C for 2 minutes. The extension reaction was 1 cycle, and 25 cycles were allowed to react. The obtained PCR product was treated with restriction enzymes KpnI and XbaI and incorporated into the KpnI and XbaI sites of the expression plasmid pYES2, which was designated as pYES2-LcOSC3. As a result, LcOSC3 is introduced in the sense direction downstream of the GAL1 promoter. Further, the obtained pYES2-LcOSC3 plasmid was introduced into the yeast mutant GIL77, which is a lanosterol synthetase-deficient strain, by the lithium acetate method. Culture conditions, expression induction by lactose, and preparation of triterpene monoalcohol fraction were carried out in the same manner as described in Kushiro, T. et al. [Eur. J. Biochem. 256, 238-244 ( 1998)]. After induction of expression by galactose, the product was extracted from the transformed yeast, purified by TLC, and analyzed for the triterpene monoalcohol fraction by LC-MS / MS. LC-MS / MS was measured by LCQ (Thermo Quest) under the following HPLC conditions.
(HPLC conditions)
Column: SUPER-ODS (diameter: 4.6mm, length: 200mm; manufactured by Tosoh)
Solvent system: 95% CH 3 CN aq., Flow rate: 1ml / min, Column temp .: 40 ℃, Detection: UV205nm, Retention time for isomultiflorenol: 23.9min.
The peak obtained from the triterpene monoalcohol fraction identified by LC-MS / MS based on comparison with the MS / MS fragment pattern of the standard isomultiflorenol is isomultiflorenol, and the compound obtained from this fraction is It was only isomultiflorenol (FIG. 1). As a result of MS and MS / MS analysis of isomultiflorenol, MS m / z 409 [M + HH 2 O] + , MS / MS (precursor ion at m / z 409) 353 (10%), 313 ( 22%), 299 (57%), 245 (65%), 231 (91%), 217 (100%), 191 (71%) were obtained. Therefore, it was concluded that this cDNA encodes isomultiphlorenol synthase (IMS1), which is one of the oxide squalene cyclases obtained from higher plants.
[0014]
Three types of oxide squalene cyclase, cycloartenol synthase (CAS1) [Plant Physiol. 121,1384 (1999)], oxide squalene cyclase (OSC2) [Plant Physiol. 122,1457 (Unknown function) 2000)], comparing the amino acid sequence of isomultiphlorenol synthase (IMS1), the amino acid sequence of IMS1 showed 51% homology with CAS1 and 50% with OSC2 (FIG. 2). Furthermore, a phylogenetic tree was created from the amino acid sequence of IMS1 and the amino acid sequence of oxidosqualene cyclase cloned from a higher plant (FIG. 3). IMS1 showed 67-66% homology with β-amylin synthase and 61-57% homology with lupeol synthase. Since the amino acid sequence of IMS1 is 67-57% less homologous with other triterpene synthases, isomultiphlorenol synthase is classified as a new class of triterpene synthases found in cucurbitaceae plants.
[0015]
Example 6 Northern blot analysis
The DIG-labeled RNA probe was prepared from BamHI-treated CAS1, EcoRI-treated OSC2, and BamHI-treated IMS1 using T7 RNA polymerase and DIG RNA Labeling Mix (Roche Diagnostic) according to the manufacturer's instructions. Total RNA was extracted using Extract-A-Plant ™ RNA Isolation Kit (Clontech). 5 μg of total RNA per lane was separated on a 1% agarose gel containing formaldehyde and blotted onto a positively charged nylon membrane (Roche Diagnostic). RNA on the membrane in hybridization buffer containing 50 mM Na-Pi buffer (pH 7.0), 50% formamide, 0.1% N-lauryl sarcosine, 7% SDS, 5xSSC, 1 mg / ml tRNA (yeast), blocking reagent Hybridization was performed using a DIG-labeled RNA probe at 50 ° C., and detection was performed using DIG Nucleic Acid Detection Kit Mix (Roche Diagnostic) according to the manufacturer's instructions (FIG. 4).
[0016]
Example 7 Time course of cell growth and bryonolic acid production The time course of cell growth and bryonolic acid production on
(Gas chromatography analysis conditions)
Column: Ultra Alloy + -17 capillary column (15m x 0.5mm id, film thickness: 1 (l, manufactured by Frontier Lab Ltd.), Column temp .: 295 ° C (isothermal), injector and detector temp .: 320 ° C, Carrier gas: He 3.5ml / min.
Production of bryonolic acid by loofah cultured cells rises later in the logarithmic growth phase. Comparison of the time course of bryonolic acid production with the mRNA level of IMS1, the mRNA level of CAS1, and the mRNA level of OSC2, the mRNA levels of the three oxidosqualene cyclases were regulated differently in loofah cells ( FIG. 6). Isomultiphlorenol synthase mRNA levels are highest on the 16th and 20th days of culture, and at this point the bryonolic acid synthesis activity is very high. However, on
[0017]
【The invention's effect】
As described above, the first successful cloning of DNA encoding isomultiflorenol synthase, and further using the cells expressing the cloned recombinant DNA, isomultiflorenol synthase, DNA encoding the enzyme and It is possible to produce isomultiflorenol and / or various terpenoids biosynthesized from this isomultiflorenol.
[0018]
[Sequence Listing]
[Brief description of the drawings]
FIG. 1 is a diagram comparing HPLC chromatograms and LC-MS / MS fragments of standard isomultiflorenol and pYES2-OSC3 transformed yeast extract.
FIG. 2 is a comparison of the amino acid sequences of CAS1, OSC2, and IMS1. Homologous amino acids are shown in white letters reversed.
FIG. 3 is a phylogenetic tree created from amino acid sequences of higher plant-derived oxide squalene cyclase. Method: UPGMA (Genetyx software). LAS, lupeol synthase; IMS, isomultiphlorenol synthase; CAS, cycloartenol synthase; CDS, cucurbitadienol synthase; OSC, oxide squalene cyclase.
FIG. 4 is a view showing restriction enzyme sites and DIG-labeled RNA probe sites of CAS1, OSC2, and IMS1.
FIG. 5 is a diagram showing a time course of cell growth and bryonolic acid production.
FIG. 6 is an electrophoretogram showing changes in IMS1 mRNA, CAS1 mRNA, and OSC2 mRNA levels during culture of loofah cells.
Claims (11)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001011612A JP4606604B2 (en) | 2001-01-19 | 2001-01-19 | Isomultiphlorenol synthase and the enzyme gene |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001011612A JP4606604B2 (en) | 2001-01-19 | 2001-01-19 | Isomultiphlorenol synthase and the enzyme gene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002209576A JP2002209576A (en) | 2002-07-30 |
| JP4606604B2 true JP4606604B2 (en) | 2011-01-05 |
Family
ID=18878728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001011612A Expired - Lifetime JP4606604B2 (en) | 2001-01-19 | 2001-01-19 | Isomultiphlorenol synthase and the enzyme gene |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4606604B2 (en) |
-
2001
- 2001-01-19 JP JP2001011612A patent/JP4606604B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002209576A (en) | 2002-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106459987B (en) | Novel method for glycosylating ginsenoside using glycosyltransferase derived from ginseng | |
| KR101802547B1 (en) | Recombinant Production of Steviol Glycosides | |
| CN107058446B (en) | A group of glycosyltransferases and their applications | |
| KR101983115B1 (en) | Methods and materials for recombinant production of saffron compounds | |
| US12247209B2 (en) | Transferase enzymes | |
| KR102338008B1 (en) | A group of UDP-glycosyltransferases and their applications to catalyze sugar chain extension | |
| CN112969785A (en) | Cellulose synthase-like enzyme and use thereof | |
| CN110452916B (en) | Hyoscyaldehyde reductase and application thereof | |
| US10066249B2 (en) | Method for producing acetylated sphingoid base | |
| Herl et al. | The VEP1 gene (At4g24220) encodes a short-chain dehydrogenase/reductase with 3-oxo-Δ4, 5-steroid 5β-reductase activity in Arabidopsis thaliana L. | |
| Nakayasu et al. | Identification of furostanol glycoside 26-O-β-glucosidase involved in steroidal saponin biosynthesis from Dioscorea esculenta | |
| CN117897480A (en) | Mouse Li Tanggao degree specific glycosyltransferase and application thereof | |
| CN110121556B (en) | Steviol glycoside hexosyltransferase and gene encoding the substance | |
| CA2392435C (en) | An isolated plant gene encoding a .beta.-amyrin synthase | |
| JP5794606B2 (en) | Plant cells that accumulate L-DOPA and use thereof | |
| CN112831481A (en) | Glycosyltransferase and method for catalyzing sugar chain extension | |
| AU2016282286A1 (en) | Methods and compositions for making ephedrine and related alkaloid compounds | |
| JP4606604B2 (en) | Isomultiphlorenol synthase and the enzyme gene | |
| US6498239B1 (en) | Sterol glycosyl transferases | |
| KR100419743B1 (en) | Nucleic acid molecule encoding a cytochrome P450 hydroxylase in brassinosteroid biosynthesis in plants | |
| US7105324B2 (en) | Nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use | |
| CN115074399B (en) | Key enzyme genes EjCYP716A1/2 and EjCYP716C1/2 for loquat triterpenic acid synthesis and their application | |
| CN117062914A (en) | Methods and compositions | |
| KR20100061465A (en) | Triterpene oxidase derived from plant belonging to genus glychyrrhiza, gene encoding the triterpene oxidase, and use of the protein or the gene | |
| US11001850B2 (en) | Constructs and methods for biosynthesis of cyclopamine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070706 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20070910 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20070910 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100623 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100823 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100908 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101006 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4606604 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131015 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |